2受体激动剂雾化吸入治疗COPD急性发作临床研究'> 布地奈德联合β2受体激动剂雾化吸入治疗C
 |
| 第1页 |
参见附件。
摘要：目的 探讨布地奈德联合β2受体激动剂雾化吸入治疗COPD急性发作临床效果。方法 选取我院近年来收治COPD急性发作患者140例，采用随机数字表法分为对照组(70例)和观察组(70例)，分别给予布地奈德单用和与沙丁胺醇雾化吸入联合治疗；比较两组患者治疗前后呼吸困难评分和肺通气功能指标等。结果 两组患者治疗后呼吸困难评分和肺通气功能指标较治疗前显著改善，且观察组患者治疗后呼吸困难评分和肺通气功能指标均优于对照组(P<0.05)。结论 布地奈德联合β2受体激动剂雾化吸入治疗COPD急性发作可有效缓解呼吸困难症状，改善肺部通气功能。
关键词：布地奈德；β2受体激动剂；雾化吸入；COPD；急性发作
Clinical Study of Budesonide Combined with β2 Receptor Agonist Inhalation in Ttreatment of Acute Exacerbations of COPD
GONG Dao-ming
(Ziyang City People's Hospital，Ziyang 641300，Sichuan，China)
Abstract：Objective To investigate clinical effects of budesonide combined withβ2 agonists in treatment of chronic obstructive pulmonary disease with acute exacerbation by inhalation.Methods 140 patients for chronic obstructive pulmonary disease with acute exacerbation were chosen in recent years in our hospital and randomly divided into two groups including control group (70 patients) with budesonide by inhalation separately and observation group (70 patients) with budesonide combined with ventolin as β2 agonists； and the dyspnea scores and lung function indexes before and after treatment of both groups were compared ......
您现在查看是摘要介绍页，详见PDF附件。